Zydus Lifesciences Limited — Important, 17-12-2024: Updates

Zydus Lifesciences Limited has finalized the sale of a 6.5% equity stake in Mylab Discovery Solutions Private Limited. The wholly owned subsidiary, Zydus Animal Health and Investments Limited (ZAHL), executed a termination deed with Rising Sun Holdings Private Limited (RHSPL), selling 65,06,500 equity shares for a total of ₹106 crore. This transaction signifies the conclusion of a prior agreement, and it was officially completed at 1:13 p.m. today. The closure of this deal may provide Zydus with enhanced liquidity and focus on its core operations, beneficial for its strategic direction moving forward.